Hopes That New Blood Test Could be Early Warning for Lung Cancer, Cizzle Biotechnology Limited Reveals

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A company founded by York University scientists is working on a blood test for the detection of early stage lung cancer. Cizzle Biotechnology Limited, a spin-out company from York University and Fujirebio Diagnostics Incorporated (FDI) have announced a co-development and licensing deal for the test.

Hey, check out all the engineering jobs. Post your resume today!

MORE ON THIS TOPIC